Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
43%(3 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_1
5
63%
Ph phase_4
1
13%
Ph phase_3
1
13%

Phase Distribution

5

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
5(71.4%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (71.4%)
Phase 31 (14.3%)
Phase 41 (14.3%)

Trials by Status

completed788%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
completed

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

NCT00042289
completedphase_1

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

NCT00977301
completedphase_1

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

NCT00307502
completedphase_1

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

NCT00877591
completedphase_3

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

NCT00450580
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00042289

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Completed
NCT00977301Phase 1

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

Completed
NCT00307502Phase 1

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Completed
NCT00877591Phase 1

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Completed
NCT00450580Phase 3

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Completed
NCT01010399Phase 4

Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

Completed
NCT01290211Phase 1

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Completed
NCT01140412Phase 1

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8